Immunomedics, Inc. (IMMU) To Present At Cowen And Company 34th Annual Health Care Conference
2/26/2014 9:00:15 AM
MORRIS PLAINS, N.J., Feb. 26, 2014 (GLOBE NEWSWIRE) -- Immunomedics, Inc. (Nasdaq:IMMU), a biopharmaceutical company primarily focused on the development of monoclonal antibody-based products for the targeted treatment of cancer, autoimmune and other serious diseases, today announced that the Company will present at Cowen and Company 34th Annual Health Care Conference on Wednesday, March 5, 2014 at 11:20 a.m. Eastern Time in Boston, Massachusetts. The presentation, which will provide a corporate overview, can be accessed at www.immunomedics.com/pdfs/company-presentation.pdf.
Help employers find you! Check out all the jobs and post your resume.
comments powered by